Replay available

Viking Therapeutics, Inc. (0VQA) Q3 2025 Earnings Call

Viking Therapeutics, Inc. (LSE: 0VQA) Q3 2025 earnings conference call, held 2025-10-22. Replay captured from the company's public earnings webcast.

Wed, October 22, 2025 at 4:30 PMendedReplay
Viking Therapeutics, Inc. (0VQA) Q3 2025 Earnings Call

Hosted by

Featured presenters

Stephanie Diaz

Manager of Investor Relations

Brian Leon

President and Chief Executive Officer

Greg Zanti

Chief Financial Officer

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Viking Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.238 Welcome to the Viking Therapeutics third quarter 2025 financial 00:00:05.238 -- 00:00:10.786 results conference call. At this time, all participants are in a listen-only mode. 00:00:10.786 -- 00:00:15.011 Following management's prepared remarks, we will hold a Q&A session. 00:00:15.011 -- 00:00:20.058 To ask a question at that time, please press the star key followed by one on your 00:00:20.058 -- 00:00:25.165 touchtone phone. If anyone has difficulty hearing the conference, please press star 00:00:25.165 -- 00:00:30.898 zero for operator assistance. As a reminder, this conference call is being recorded today, 00:00:30.898 -- 00:00:34.404 October 22, 2025. I 00:00:34.404 -- 00:00:40.213 would now like to turn the conference over to Vikings Manager of Investor Relations, 00:00:40.213 -- 00:00:44.311 Stephanie Diaz. Please go ahead, Stephanie. 00:00:44.311 -- 00:00:47.554 Hello, and thank you all for participating in today's call. 00:00:47.554 -- 00:00:53.601 Joining me today is Brian Leon, Vikings President and CEO, and Greg Zanti, Vikings CFO. 00:00:53.601 -- 00:00:57.825 Before we begin, I'd like to caution that comments made during this conference call today, 00:00:57.825 -- 00:01:00.386 October 22, 2025, 00:01:00.388 -- 00:01:04.373 will contain forward-looking statements under the safe harbor provisions of the U.S. 00:01:04.373 -- 00:01:08.377 Private Securities Litigation Reform Act of 1995, including 00:01:08.377 -- 00:01:13.442 statements about Vikings' expectations regarding its development activities, timelines, 00:01:13.442 -- 00:01:17.930 and milestones. Forward-looking statements are subject to risks and uncertainties that 00:01:17.930 -- 00:01:23.054 could cause actual results to differ materially and adversely, and re...